155 related articles for article (PubMed ID: 11522659)
1. The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure.
Okegawa T; Pong RC; Li Y; Bergelson JM; Sagalowsky AI; Hsieh JT
Cancer Res; 2001 Sep; 61(17):6592-600. PubMed ID: 11522659
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application.
Pong RC; Roark R; Ou JY; Fan J; Stanfield J; Frenkel E; Sagalowsky A; Hsieh JT
Cancer Res; 2006 Sep; 66(17):8822-8. PubMed ID: 16951199
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells.
Sachs MD; Ramamurthy M; Poel Hv; Wickham TJ; Lamfers M; Gerritsen W; Chowdhury W; Li Y; Schoenberg MP; Rodriguez R
Cancer Gene Ther; 2004 Jul; 11(7):477-86. PubMed ID: 15118762
[TBL] [Abstract][Full Text] [Related]
4. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy.
Li Y; Pong RC; Bergelson JM; Hall MC; Sagalowsky AI; Tseng CP; Wang Z; Hsieh JT
Cancer Res; 1999 Jan; 59(2):325-30. PubMed ID: 9927041
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of coxsackie adenovirus receptor on invasive and metastatic phenotype of ovarian cancer cell line SKOV3].
Wang BB; Chen G; Li FJ; Zhou JF; Lu YP; Ma D
Ai Zheng; 2005 Sep; 24(9):1054-8. PubMed ID: 16159424
[TBL] [Abstract][Full Text] [Related]
6. The growth inhibitory effect of p21 adenovirus on human bladder cancer cells.
Hall MC; Li Y; Pong RC; Ely B; Sagalowsky AI; Hsieh JT
J Urol; 2000 Mar; 163(3):1033-8. PubMed ID: 10688044
[TBL] [Abstract][Full Text] [Related]
7. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A
Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells.
Pong RC; Lai YJ; Chen H; Okegawa T; Frenkel E; Sagalowsky A; Hsieh JT
Cancer Res; 2003 Dec; 63(24):8680-6. PubMed ID: 14695181
[TBL] [Abstract][Full Text] [Related]
9. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy.
Okegawa T; Li Y; Pong RC; Bergelson JM; Zhou J; Hsieh JT
Cancer Res; 2000 Sep; 60(18):5031-6. PubMed ID: 11016624
[TBL] [Abstract][Full Text] [Related]
10. A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells.
Okegawa T; Sayne JR; Nutahara K; Pong RC; Saboorian H; Kabbani W; Higashihara E; Hsieh JT
J Urol; 2007 Mar; 177(3):1148-56. PubMed ID: 17296436
[TBL] [Abstract][Full Text] [Related]
11. Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer.
Matsumoto K; Shariat SF; Ayala GE; Rauen KA; Lerner SP
Urology; 2005 Aug; 66(2):441-6. PubMed ID: 16040097
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of coxsackie and adenovirus receptor inhibit growth of human bladder cancer cell in vitro and in vivo.
Zhang LL; He DL; Li X; Li L; Zhu GD; Zhang D; Wang XY
Acta Pharmacol Sin; 2007 Jun; 28(6):895-900. PubMed ID: 17506949
[TBL] [Abstract][Full Text] [Related]
13. A novel role for the coxsackie adenovirus receptor in mediating tumor formation by lung cancer cells.
Qin M; Escuadro B; Dohadwala M; Sharma S; Batra RK
Cancer Res; 2004 Sep; 64(18):6377-80. PubMed ID: 15374942
[TBL] [Abstract][Full Text] [Related]
14. Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model.
Melquist JJ; Kacka M; Li Y; Malaeb BS; Elmore J; Baseman AG; Hsieh JT; Koeneman KS
Urol Oncol; 2006; 24(4):362-71. PubMed ID: 16818192
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells.
Chen CL; Sung J; Cohen M; Chowdhury WH; Sachs MD; Li Y; Lakshmanan Y; Yung BY; Lupold SE; Rodriguez R
J Pharmacol Exp Ther; 2006 Nov; 319(2):533-42. PubMed ID: 16868035
[TBL] [Abstract][Full Text] [Related]
16. The coxsackie adenovirus receptor inhibits cancer cell migration.
Brüning A; Runnebaum IB
Exp Cell Res; 2004 Aug; 298(2):624-31. PubMed ID: 15265708
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition.
Lacher MD; Tiirikainen MI; Saunier EF; Christian C; Anders M; Oft M; Balmain A; Akhurst RJ; Korn WM
Cancer Res; 2006 Feb; 66(3):1648-57. PubMed ID: 16452224
[TBL] [Abstract][Full Text] [Related]
18. In vitro adenoviral vector p53-mediated transduction and killing correlates with expression of coxsackie-adenovirus receptor and alpha(nu)beta5 integrin in SUDHL-1 cells derived from anaplastic large-cell lymphoma.
Turturro F; Seth P; Link CJ
Clin Cancer Res; 2000 Jan; 6(1):185-92. PubMed ID: 10656449
[TBL] [Abstract][Full Text] [Related]
19. In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL.
El-Zawahry A; Lu P; White SJ; Voelkel-Johnson C
Cancer Gene Ther; 2006 Mar; 13(3):281-9. PubMed ID: 16167063
[TBL] [Abstract][Full Text] [Related]
20. [Enhancive effect of histone deacetylase inhibitor trichostatin a on transfection efficiency of adenovirus in ovarian carcinoma cell line A2780].
Chen G; Wang BB; Li FJ; Liu DY; Zhou JF; Lu YP; Ma D
Ai Zheng; 2005 Oct; 24(10):1196-200. PubMed ID: 16219132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
